Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY.

Head Neck. 2013 Nov;35(11):1641-6. doi: 10.1002/hed.23199. Epub 2013 Jan 16.

PMID:
23322545
2.

Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS.

Head Neck. 2013 Nov;35(11):1634-40. doi: 10.1002/hed.23200. Epub 2013 Jan 16.

PMID:
23322563
3.

Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.

Bozec A, Benezery K, Chamorey E, Ettaiche M, Vandersteen C, Dassonville O, Poissonnet G, Riss JC, Hannoun-Lévi JM, Chand ME, Leysalle A, Saada E, Sudaka A, Haudebourg J, Hebert C, Falewee MN, Demard F, Santini J, Peyrade F.

Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2681-7. doi: 10.1007/s00405-015-3785-4. Epub 2015 Sep 22.

PMID:
26395117
4.

Factors associated with gastrostomy tube dependence after concurrent chemoradiotherapy for hypopharyngeal cancer.

Murono S, Tsuji A, Endo K, Kondo S, Wakisaka N, Yoshizaki T.

Support Care Cancer. 2015 Feb;23(2):457-62. doi: 10.1007/s00520-014-2388-8. Epub 2014 Aug 17.

PMID:
25129396
5.

Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.

Paximadis P, Yoo G, Lin HS, Jacobs J, Sukari A, Dyson G, Christensen M, Kim H.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1515-21. doi: 10.1016/j.ijrobp.2011.04.064. Epub 2011 Jun 12.

6.

A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.

Homma A, Hatakeyama H, Mizumachi T, Kano S, Sakashita T, Kuramoto R, Nakamaru Y, Onimaru R, Tsuchiya K, Yoshida D, Yasuda K, Shirato H, Fukuda S.

PLoS One. 2016 Aug 24;11(8):e0161734. doi: 10.1371/journal.pone.0161734. eCollection 2016.

7.

A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS.

Cancer. 2015 Jan 15;121(2):294-301. doi: 10.1002/cncr.29022. Epub 2014 Oct 6.

8.

Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.

Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB.

Radiat Oncol. 2015 Apr 18;10:93. doi: 10.1186/s13014-015-0408-6.

9.

Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?

Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P.

Cancer. 2001 May 1;91(9):1785-90.

PMID:
11335904
10.

Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.

Katsoulakis E, Riaz N, Hu M, Morris L, Sherman E, McBride S, Lee N.

Laryngoscope. 2016 Mar;126(3):620-6. doi: 10.1002/lary.25509. Epub 2015 Nov 24.

11.
12.

Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.

Chapuy CI, Annino DJ, Snavely A, Li Y, Tishler RB, Norris CM, Haddad RI, Goguen LA.

Otolaryngol Head Neck Surg. 2011 Sep;145(3):428-34. doi: 10.1177/0194599811403075.

13.

Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.

Laryngoscope. 2001 Jun;111(6):1079-87.

PMID:
11404625
14.

Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.

Tennant PA, Cash E, Bumpous JM, Potts KL.

Head Neck. 2014 Nov;36(11):1628-33. doi: 10.1002/hed.23508. Epub 2013 Dec 18.

PMID:
24115178
15.

Functional outcomes of chemoradiation in patients with head and neck cancer.

Tulunay-Ugur OE, McClinton C, Young Z, Penagaricano JA, Maddox AM, Vural E.

Otolaryngol Head Neck Surg. 2013 Jan;148(1):64-8. doi: 10.1177/0194599812459325. Epub 2012 Sep 5.

PMID:
22951428
16.

Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience.

Nakajima A, Nishiyama K, Morimoto M, Nakamura S, Suzuki O, Kawaguchi Y, Miyagi K, Fujii T, Yoshino K.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e129-35. doi: 10.1016/j.ijrobp.2011.03.040. Epub 2011 Jun 2.

PMID:
21640496
17.

Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.

Strom T, Trotti AM, Kish J, Rao NG, McCaffrey J, Padhya TA, Lin HY, Fulp W, Caudell JJ.

JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1242-6. doi: 10.1001/jamaoto.2013.5193.

PMID:
24136493
18.

Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma.

Masuda M, Matsuo M, Aso T, Kiyohara H, Rikimaru F, Kunitake N, Higaki Y.

Head Neck. 2015 Sep;37(9):1290-6. doi: 10.1002/hed.23759. Epub 2014 Jul 24.

PMID:
24816950
19.
20.

Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.

Mok G, Gauthier I, Jiang H, Huang SH, Chan K, Witterick IJ, O'Sullivan B, Waldron JN, Bayley AJ, Cho BC, Cummings BJ, Dawson LA, Hope AJ, Kim JJ, Ringash J.

Head Neck. 2015 May;37(5):655-61. doi: 10.1002/hed.23649. Epub 2014 Apr 25.

PMID:
24590756

Supplemental Content

Support Center